Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pilar Ricart Martí"'
Autor:
Oriol Plans Galván, Hipólito Pérez Moltó, Ariadna Fabià-Mayans, Blanca Xicoy, José Luis Mate, Pilar Ricart Martí
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 11 (2018)
Hydroxyurea (HU) is a drug frequently used in the treatment of chronic myeloproliferative neoplasms. The most common side effects of this drug are pancytopenia, digestive and skin disorders. Respiratory complications are rare and there are less than
Externí odkaz:
https://doaj.org/article/f85a4d85a45445ea8789af9c4abd9caa
Autor:
Itziar Martínez de Lagrán Zurbano, Ma Luisa Bordejé Laguna, Carlos Pollán Guisasola, Pilar Ricart Martí, Constanza Dolores Viñas Soria, Esther Mor Marco, Pilar Marcos-Neira
Publikováno v:
Clinical Nutrition (Edinburgh, Scotland)
Background & aims Dysphagia can be a consequence of prolonged hospitalization in intensive care units (ICUs) due to severe SARS-CoV-2 pneumonia. This study aims at Identifying the risk factors for dysphagia in ICU patients with COVID-19 pneumonia req
Autor:
Mª Luisa Bordeje Laguna, Pilar Marcos-Neira, Itziar Martínez de Lagrán Zurbano, Esther Mor Marco, Carlos Pollan Guisasola, Constanza Dolores Viñas Soria, Pilar Ricart Martí
BACKGROUND. Severe SARS-CoV-2 pneumonia has brought intensive care units (ICUs) and the consequences of prolonged hospitalisation, such as dysphagia, into focus.METHODS. Study population: Patients with severe pneumonia due to SARS-CoV-2 who required
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84f61e91e273611ff365156763a373c2
https://doi.org/10.21203/rs.3.rs-206615/v1
https://doi.org/10.21203/rs.3.rs-206615/v1